Thu, March 14, 2024

Jonathan Wolleben Maintained (SPRB) at Buy with Decreased Target to $3 on, Mar 14th, 2024

Jonathan Wolleben of JMP Securities, Maintained "Spruce Biosciences, Inc." (SPRB) at Buy with Decreased Target from $8 to $3 on, Mar 14th, 2024.

Jonathan, nor any peers, have made any analyst calls on SPRB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30